We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Arrowhead Begins Phase 1 Trial of RNAi Therapeutic ARC-520

News   Jul 24, 2013

 
Arrowhead Begins Phase 1 Trial of RNAi Therapeutic ARC-520
 
 
 

RELATED ARTICLES

A Research Partnership to Find Treatments for Neurological Disorders

News

BioMotiv and Cure Network Dolby Acceleration Partners launch a collaboration to find better treatments for brain disorders.

READ MORE

PCR Assay Helps ID Sarcoma Mutations

News

Sarcomas are rare tumors that are often misdiagnosed. A report in the Journal of Molecular Diagnostics describes a new assay, anchored multiplex PCR (AMP)-based targeted next-generation-sequencing (NGS), that is better able to identify genetic diagnostic markers of the cancer.

READ MORE

Breast Cancer Vulnerability Could Be Exploited by Future Targeted Drugs

News

Researchers have identified a vulnerability in some breast cancer cells of a certain type – called triple negative breast cancer – that could be exploited by future targeted drugs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE